Opportunity Information: Apply for RFA HD 22 004

The Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed) opportunity (RFA HD 22 004) is a National Institutes of Health program project grant designed to push forward a coordinated, team-based understanding of major congenital structural malformations. The central goal is to fund research programs that do more than run parallel studies; they are expected to be genuinely integrated and synergistic, bringing together basic developmental biology, human genetics, translational science, and clinically grounded investigations to clarify how and why specific birth defects arise. The focus is on the developmental mechanisms and genetic basis of significant human malformations, with an emphasis on connecting what is learned in model organisms to what is observed in people.

A defining feature of this FOA is the required program structure. Each funded application must be organized as a program project composed of three distinct but tightly linked research projects, supported by shared cores that provide common resources, services, or infrastructure for the overall program. The projects cannot be a collection of unrelated aims; they must be unified by a single central theme, objective, or scientific focus. That theme must revolve around a specific major developmental defect or malformation that can be studied in both humans and an animal model in a way that is meaningfully analogous, whether the similarity is genetic (same or related genes), mechanistic (shared causal biology), biological (comparable developmental processes), or phenotypic (similar malformation outcomes). The FOA also makes clear that the component projects should converge on shared developmental biology such as a gene, pathway, process, mechanism, or phenotype, reinforcing the expectation that the projects inform one another rather than merely coexisting.

The FOA requires a deliberate balance across basic and human-focused research. At least one component project must be basic research using an animal model system, and at least one must be clinical or translational in nature. This requirement is meant to ensure that mechanistic discoveries in a model system can be tied to human disease biology and, conversely, that observations from patients, clinical cohorts, or human-derived data can shape the mechanistic questions tested in the lab. The announcement allows essentially any animal model, mammalian or non-mammalian, as long as it credibly advances the shared program theme and supports cross-species comparison to human malformations.

From an administrative and eligibility standpoint, this is a discretionary grant program under the U.S. Department of Health and Human Services, National Institutes of Health, with an activity category aligned to health and social services (CFDA 93.865). A wide range of applicant organizations are eligible, including federal recognized tribal governments and tribal organizations, state and local governments, public and private institutions of higher education, independent school districts, special district governments, public housing authorities/Indian housing authorities, nonprofit organizations (with or without 501(c)(3) status), and for-profit entities (including small businesses). The “Clinical Trial Not Allowed” designation signals that applications should not propose clinical trials as defined by NIH policy, even though clinical and translational research components are expected; in practice, that steers applicants toward mechanistic, observational, correlative, or preclinical translational work rather than interventional clinical testing.

In terms of funding scale and competition, the opportunity listed an award ceiling of $1,000,000 and anticipated making about two awards. The original posting information indicates a creation date of April 19, 2021, and an original closing date of July 29, 2021. Overall, the FOA is targeted at research teams prepared to build an integrated, multi-project program that can connect developmental biology and genetics across model systems and human studies to explain the origins of a well-defined class of structural birth defects, using shared cores and a tightly coordinated scientific strategy to produce outcomes that would be difficult to achieve through single-project funding.

  • The Department of Health and Human Services, National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
  • This funding opportunity was created on Apr 19, 2021.
  • Applicants must submit their applications by Jul 29, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA HD 22 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the purpose of the Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed) opportunity (RFA HD 22 004)?

This NIH program project grant (P01) is intended to advance a coordinated, team-based understanding of major congenital structural malformations. The goal is to support integrated, synergistic research programs that combine basic developmental biology, human genetics, translational science, and clinically grounded investigations to clarify how and why specific structural birth defects arise.

What kinds of birth defects are the focus of this funding opportunity?

The focus is on significant human congenital structural malformations. Each application is expected to center on a specific major developmental defect or malformation that can be studied in both humans and an animal model in a meaningfully analogous way.

What is a P01 program project in the context of this FOA?

Under this FOA, the program must be organized as a program project composed of three distinct but tightly linked research projects, supported by shared cores. The projects must be unified by a single central theme, objective, or scientific focus and must be designed to inform one another rather than function as parallel, unrelated studies.

How many research projects are required in an application?

Each funded application is required to include three component research projects.

Are shared cores required, and what are they for?

Yes. The program projects are supported by shared cores that provide common resources, services, or infrastructure for the overall program. The cores are intended to strengthen integration and efficiency across the three projects.

What does it mean that the projects must be "integrated and synergistic"?

It means the three research projects cannot simply be separate studies grouped under one application. They must be deliberately coordinated around a single theme and designed so that findings, tools, data, or approaches from one project inform and strengthen the others, producing outcomes that would be difficult to achieve through single-project funding.

What qualifies as an acceptable "central theme" for the program?

The central theme must revolve around a specific major developmental defect or malformation that can be studied in both humans and an animal model. The cross-species connection may be based on genetic similarity (same or related genes), mechanistic similarity (shared causal biology), biological similarity (comparable developmental processes), or phenotypic similarity (similar malformation outcomes). The FOA also emphasizes convergence on shared developmental biology such as a gene, pathway, process, mechanism, or phenotype.

Does the FOA require both basic research and human-focused research?

Yes. At least one component project must be basic research using an animal model system, and at least one component project must be clinical or translational in nature. This is intended to connect mechanistic discoveries in model systems to human disease biology and to ensure that human observations can shape mechanistic questions tested in the lab.

What kinds of animal models are allowed?

The FOA allows essentially any animal model, mammalian or non-mammalian, as long as it credibly advances the shared program theme and supports meaningful cross-species comparison to human malformations.

What does "Clinical Trial Not Allowed" mean for this opportunity?

The "Clinical Trial Not Allowed" designation indicates that applications should not propose clinical trials as defined by NIH policy. Even though clinical and translational research components are expected, the FOA steers applicants toward mechanistic, observational, correlative, or preclinical translational work rather than interventional clinical testing.

Can an application include clinical or translational research without proposing a clinical trial?

Yes. The FOA expects clinical or translational components, but they must not constitute a clinical trial under NIH policy. Based on the description provided, appropriate approaches would generally be mechanistic, observational, correlative, or preclinical translational work rather than interventional testing.

Which federal agency is offering this grant?

This is a discretionary grant program under the U.S. Department of Health and Human Services, National Institutes of Health (NIH).

What is the activity category or assistance listing associated with this opportunity?

The activity category is aligned to health and social services, with CFDA 93.865 listed in the opportunity description.

What types of organizations are eligible to apply?

A wide range of applicant organizations are eligible, including: federally recognized tribal governments and tribal organizations; state and local governments; public and private institutions of higher education; independent school districts; special district governments; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status); and for-profit entities (including small businesses).

How many awards were anticipated?

The opportunity anticipated making about two awards.

What was the award ceiling listed for this opportunity?

The listed award ceiling was $1,000,000.

When was the opportunity originally posted and when did it close?

The original posting information indicates a creation date of April 19, 2021, and an original closing date of July 29, 2021.

Is this opportunity designed for single-investigator projects or team programs?

This opportunity is designed for coordinated team programs. It targets research teams prepared to build an integrated, multi-project program with three linked projects and shared cores, connecting developmental biology and genetics across model systems and human studies.

What is the main scientific emphasis of the FOA?

The FOA emphasizes understanding the developmental mechanisms and genetic basis of major human structural malformations, with a strong focus on connecting what is learned in model organisms to what is observed in people.

Can the three projects address different aspects of the same defect?

Yes, as long as they are unified by a single central theme tied to a specific malformation and converge on shared developmental biology (for example, a common gene, pathway, process, mechanism, or phenotype) so that the projects are genuinely integrated and mutually informative.

Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health

Browse more opportunities from the same category: Health, Income Security and Social Services

Next opportunity: Workforce Development Strategies Supporting the Solar Industry

Previous opportunity: Conservation Collaboration Grants Agreements Fiscal Year (FY) 2021 Announcement for Program Funding – SOUTH DAKOTA

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HD 22 004

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HD 22 004) also looked into and applied for these:

Funding Opportunity
Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01) Apply for PAR 16 366

Funding Number: PAR 16 366
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Understanding HIV Persistence in Infants (R01) Apply for RFA AI 16 064

Funding Number: RFA AI 16 064
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
NICHD Laboratory of Developmental Biology (R24) Apply for PAR 16 396

Funding Number: PAR 16 396
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Understanding and Addressing the Multi-level Influences on Uptake and Adherence to HIV Prevention Strategies Among Adolescent Girls and Young Women in Sub-Saharan Africa (R21) Apply for RFA MH 17 555

Funding Number: RFA MH 17 555
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $200,000
Understanding and Addressing the Multi-level Influences on Uptake and Adherence to HIV Prevention Strategies Among Adolescent Girls and Young Women in Sub-Saharan Africa (R01) Apply for RFA MH 17 550

Funding Number: RFA MH 17 550
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 17 017

Funding Number: RFA HD 17 017
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Trophoblast Differentiation and Function (R21) Apply for PA 16 444

Funding Number: PA 16 444
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $200,000
Trophoblast Differentiation and Function (R01) Apply for PA 16 445

Funding Number: PA 16 445
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Learning Disabilities Research Centers (P50) Apply for RFA HD 17 006

Funding Number: RFA HD 17 006
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $1,400,000
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01) Apply for PAR 17 005

Funding Number: PAR 17 005
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $499,999
Population Dynamics Centers Research Infrastructure Program FY 2017 (P2C) Apply for RFA HD 17 007

Funding Number: RFA HD 17 007
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Rehabilitation Research Career Development Programs (K12) Apply for RFA HD 17 021

Funding Number: RFA HD 17 021
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $715,000
Pediatric Scientist Development Program (K12) Apply for RFA HD 17 023

Funding Number: RFA HD 17 023
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $1,400,000
Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time (R01) Apply for RFA HD 18 003

Funding Number: RFA HD 18 003
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $499,000
Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time (R21) Apply for RFA HD 18 004

Funding Number: RFA HD 18 004
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $200,000
Integrative Research in Gynecologic Health (R01) Apply for RFA HD 18 017

Funding Number: RFA HD 18 017
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $499,999
Fertility Status as a Marker for Overall Health (R01) Apply for PA 17 091

Funding Number: PA 17 091
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Fertility Status as a Marker for Overall Health (R21) Apply for PA 17 092

Funding Number: PA 17 092
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $200,000
Zika Virus (ZIKV) Complications (R21) Apply for PA 17 085

Funding Number: PA 17 085
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $200,000
NCMRR Early Career Research Award (R03) Apply for PAR 17 161

Funding Number: PAR 17 161
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $100,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 22 004", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: